Target intelligence / Profile preview

Skin capillary permeability

Molecular classification
Other (Physiological Process)
01

Overview

Skin capillary permeability is a fundamental physiological process describing the rate of exchange of fluids, solutes, and macromolecules between the blood within dermal capillaries and the surrounding interstitial space [1, 11]. This process is essential for maintaining skin homeostasis, delivering nutrients, and facilitating the recruitment of immune cells during an inflammatory response [2, 3]. It is regulated by the structural integrity of the vascular endothelium, specifically the tight junctions (e.g., Claudin-5, ZO-1) and adherens junctions, which are modulated by various biochemical signals [4, 10]. Pathological increases in permeability are observed in conditions such as diabetes mellitus, systemic sclerosis, and acute burn injuries, where they contribute to the formation of edema and subsequent tissue ischemia [1, 2, 11]. While not a single molecular target, skin capillary permeability is a key therapeutic endpoint for drugs that target the Vascular Endothelial Growth Factor (VEGF) pathway or histamine receptors to manage leakage and inflammation [1, 6, 9]. Conversely, stabilizing agents like calcium dobesilate are used to preserve endothelial barrier function and prevent pathological extravasation in chronic microvascular diseases [4].

Other names
Dermal microvascular permeabilityCutaneous capillary permeabilitySkin microvascular leakageCapillary sodium fluorescein leakage
02

Mechanism of action

Modulation of endothelial tight junctions, inhibition of VEGF-mediated signaling, or antagonism of vasoactive receptors (e.g., H1 histamine receptors, B2 bradykinin receptors) to alter the rate of trans-endothelial fluid and solute transport [1, 4, 6].

03

Biological functions

Microvascular exchangeInflammationFluid homeostasisImmune cell recruitmentNutrient and waste transport
04

Disease associations

Diabetes mellitusInflammationSystemic sclerosisBurn injuryEdemaChronic venous insufficiencySepsis
05

Safety considerations

Tissue edemaImpaired wound healingSystemic vascular leak syndromeHypotensionImpaired delivery of systemic therapies to target tissues
06

Interacting drugs

Bevacizumab

7 more in the full profile.

07

Biomarkers

Sodium fluorescein (NaF) leakageEvans blue dye extravasationFITC-dextran clearanceTissue edema (interstitial fluid volume)Trans-endothelial electrical resistance (TEER)

Beyond the preview

Go deeper on Skin capillary permeability.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Skin capillary permeability.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call